Literature DB >> 7990139

Structure determination of aquomet porcine hemoglobin at 2.8 A resolution.

D S Katz1, S P White, W Huang, R Kumar, D W Christianson.   

Abstract

Considerable attention is currently focused on hemoglobins from lower mammals, such as the pig, for potential use in cell-free blood substitute preparations safe for use in humans. As the first step in the elucidation of structure-function relationships in porcine hemoglobin, we have determined the three-dimensional structure of aquomet porcine hemoglobin at 2.8 A resolution. Overall, the porcine hemoglobin tetramer is structurally similar to that of human oxyhemoglobin, and the r.m.s. deviation of all backbone atoms (minus five residues at the amino and carboxyl termini of each subunit) is 0.8 A. This similarity is not unexpected given that human and porcine hemoglobins exhibit 85% sequence identity. However, regions of subtle structural differences are implicated in subtle functional differences between the two proteins, such as the 20 to 25% inhibition of the alkaline Bohr effect and the accompanying reduction in oxygen-linked chloride binding observed for porcine hemoglobin. The structural similarity of these two mammalian hemoglobins also rationalizes the novel hybridization behavior of pig and human subunits in transgenic pigs expressing both porcine and human hemoglobins in porcine erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990139     DOI: 10.1006/jmbi.1994.1751

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  The X-ray structure determination of bovine carbonmonoxy hemoglobin at 2.1 A resoultion and its relationship to the quaternary structures of other hemoglobin crystal froms.

Authors:  M K Safo; D J Abraham
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

2.  Circe's haemoglobins, pig-human hybrids: functional characterization and structural considerations.

Authors:  M T Sanna; B Giardina; M Pellegrini; A Olianas; I Messana; M Castagnola; M Corda
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

3.  Chimeric hemoglobins--hybrids of human and swine hemoglobin: assembly and stability of interspecies hybrids.

Authors:  M J Rao; B N Manjula; R Kumar; A S Acharya
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

Review 4.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

5.  Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease.

Authors:  Takayuki Yamamoto; Mohamed H Bikhet; Marisa B Marques; Huy Q Nguyen; Yehua Cui; Mariyam Javed; Syed Sikandar Raza; David Ayares; Hayato Iwase; David K C Cooper; Hidetaka Hara
Journal:  Transfusion       Date:  2021-09-22       Impact factor: 3.157

6.  Quantitative validation of MRI mapping of cerebral venous oxygenation with direct blood sampling: A graded-O2 study in piglets.

Authors:  Dengrong Jiang; Raymond C Koehler; Xiuyun Liu; Ewa Kulikowicz; Jennifer K Lee; Hanzhang Lu; Peiying Liu
Journal:  Magn Reson Med       Date:  2021-03-23       Impact factor: 3.737

7.  Analyzing pepsin degradation assay conditions used for allergenicity assessments to ensure that pepsin susceptible and pepsin resistant dietary proteins are distinguishable.

Authors:  Rong Wang; Thomas C Edrington; S Bradley Storrs; Kathleen S Crowley; Jason M Ward; Thomas C Lee; Zi L Liu; Bin Li; Kevin C Glenn
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

8.  Influence of reactive species on the modification of biomolecules generated from the soft plasma.

Authors:  Pankaj Attri; Naresh Kumar; Ji Hoon Park; Dharmendra Kumar Yadav; Sooho Choi; Han S Uhm; In Tae Kim; Eun Ha Choi; Weontae Lee
Journal:  Sci Rep       Date:  2015-02-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.